VCM
TMO icon

Versant Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Versant Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Sell
858
-440
-34% -$211K 0.04% 342
2026
Q1 		$638K Buy
1,298
+297
+30% +$161K 0.06% 208
2025
Q4 		$580K Sell
1,001
-107
-10% -$60.5K 0.07% 188
2025
Q3 		$537K Buy
1,108
+351
+46% +$163K 0.07% 183
2025
Q2 		$307K Sell
757
-252
-25% -$105K 0.05% 313
2025
Q1 		$502K Buy
1,009
+511
+103% +$277K 0.08% 155
2024
Q4 		$259K Sell
498
-2
-0.4% -$1.1K 0.06% 149
2024
Q3 		$309K Buy
500
+66
+15% +$39.1K 0.07% 118
2024
Q2 		$240K Buy
434
+202
+87% +$116K 0.06% 126
2024
Q1 		$135K Hold
232
– – 0.04% 157
2023
Q4 		$123K Sell
232
-4
-2% -$1.94K 0.04% 163
2023
Q3 		$119K Buy
236
+9
+4% +$4.8K 0.04% 158
2023
Q2 		$118K Sell
227
-16
-7% -$8.63K 0.04% 167
2023
Q1 		$140K Sell
243
-9
-4% -$5.07K 0.05% 145
2022
Q4 		$139K Sell
252
-349
-58% -$185K 0.05% 131
2022
Q3 		$305K Buy
601
+1
+0.2% +$560 0.12% 79
2022
Q2 		$326K Buy
600
+4
+0.7% +$2.2K 0.12% 80
2022
Q1 		$352K Sell
596
-162
-21% -$93.1K 0.11% 81
2021
Q4 		$506K Hold
758
– – 0.17% 67
2021
Q3 		$433K Buy
758
+8
+1% +$4.39K 0.15% 68
2021
Q2 		$378K Buy
750
+16
+2% +$7.55K 0.14% 71
2021
Q1 		$335K Buy
734
+44
+6% +$21K 0.12% 80
2020
Q4 		$321K Hold
690
– – 0.13% 73
2020
Q3 		$304K Hold
690
– – 0.14% 74
2020
Q2 		$250K Hold
690
– – 0.11% 80
2020
Q1 		$195K Sell
690
-25
-3% -$7.88K 0.1% 85
2019
Q4 		$232K Sell
715
-12
-2% -$3.64K 0.12% 74
2019
Q3 		$211K Sell
727
-16
-2% -$4.58K 0.1% 83
2019
Q2 		$218K Sell
743
-99
-12% -$27.3K 0.1% 83
2019
Q1 		$230K Sell
842
-19
-2% -$4.73K 0.1% 85
2018
Q4 		$192K Hold
861
– – 0.09% 92
2018
Q3 		$210K Sell
861
-2
-0.2% -$460 0.09% 90
2018
Q2 		$178K Sell
863
-13
-1% -$2.76K 0.08% 102
2018
Q1 		$180K Sell
876
-18
-2% -$3.78K 0.07% 107
2017
Q4 		$169K Sell
894
-9
-1% -$1.72K 0.07% 112
2017
Q3 		$170K Hold
903
– – 0.09% 87
2017
Q2 		$157K Hold
903
– – 0.09% 89
2017
Q1 		$138K Hold
903
– – 0.08% 101
2016
Q4 		$127K Sell
903
-16
-2% -$2.36K 0.07% 102
2016
Q3 		$146K Sell
919
-1
-0.1% -$154 0.08% 97
2016
Q2 		$135K Hold
920
– – 0.08% 99
2016
Q1 		$130K Buy
920
+5
+0.5% +$670 0.08% 98
2015
Q4 		$129K Buy
+915
New +$122K 0.08% 98

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Versant Capital Management's TMO Position: Q2 2026 in Review

Versant Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 34% in Q2 2026, selling an estimated $211K and leaving 858 shares worth $430K. The position accounts for 0.04% of the portfolio, ranked #342.

Versant Capital Management first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. The position peaked at $638K in Q1 2026. 610 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Versant Capital Management held 858 shares of Thermo Fisher Scientific worth $430K as of Q2 2026.
  • Versant Capital Management sold 440 Thermo Fisher Scientific shares in Q2 2026, an estimated $211K.
  • Thermo Fisher Scientific made up 0.04% of Versant Capital Management's portfolio in Q2 2026, its #342 holding.
  • Versant Capital Management first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Thermo Fisher Scientific position peaked at $638K in Q1 2026.
  • 610 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.